Published in J Endocrinol on June 01, 1985
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Incorporation and distribution of strontium in bone. Bone (2001) 1.40
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 1.38
Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem (2001) 1.38
Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med (1980) 1.37
The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res (1998) 1.31
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest (1998) 1.30
Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30
Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab (1978) 1.27
Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem (2001) 1.24
Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res (1983) 1.17
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism (2004) 1.11
Agenesis of the right pulmonary artery in a young asymptomatic girl. Eur Respir J (1991) 1.11
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ (2006) 1.10
Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Miner Res (1996) 1.08
Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res (2005) 1.03
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 1.00
Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem (1998) 1.00
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism (2002) 0.99
The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol (1988) 0.99
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res (2000) 0.98
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res (2004) 0.97
The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res (2000) 0.97
Glycol methacrylate as an embedding medium for bone. Stain Technol (1987) 0.96
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. J Cell Physiol (2000) 0.95
Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone (1996) 0.95
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis (2013) 0.94
Vitamin D dependency: replacement therapy with calcitriol? J Pediatr (1981) 0.93
Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J Cell Biochem (1997) 0.93
Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion. Eur J Biochem (1989) 0.93
Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int (1988) 0.93
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet (1995) 0.92
Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol Histopathol (2004) 0.92
Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res (1999) 0.91
Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab (1982) 0.91
Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int (1982) 0.91
Skeletal unloading induces osteoblast apoptosis and targets alpha5beta1-PI3K-Bcl-2 signaling in rat bone. Exp Cell Res (2006) 0.90
Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem (1998) 0.90
Temporal variation of c-Fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem (1995) 0.90
Effects of iron overload on bone remodeling in pigs. Am J Pathol (1984) 0.89
c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells. Mol Endocrinol (1995) 0.89
Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae. Bone (1988) 0.89
Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology (1994) 0.89
Decreased bone formation in osteoporotic patients compared with age-matched controls. Calcif Tissue Int (1989) 0.89
Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. Metabolism (1986) 0.88
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol (2001) 0.88
The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1974) 0.88
Bone histological heterogeneity in postmenopausal osteoporosis: a sequential histomorphometric study. Bone (1987) 0.87
Bone histomorphometric reproducibility in normal patients. Calcif Tissue Int (1981) 0.87
Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine (1997) 0.87
Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J Biol Chem (2000) 0.87
Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J Cell Biochem (1999) 0.87
Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett (1998) 0.87
An immortalized osteogenic cell line derived from mouse teratocarcinoma is able to mineralize in vivo and in vitro. J Cell Biol (1990) 0.87
Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int (1993) 0.87
Effects of low doses of strontium on bone quality and quantity in rats. Bone (1990) 0.87
Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells. Cytokine (1995) 0.86
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis (2013) 0.86
Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine (1999) 0.86
Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype. Calcif Tissue Int (1999) 0.86
Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells. J Bone Miner Res (2001) 0.86
Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology). Proc R Soc Med (1967) 0.86
Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab (1985) 0.86
The effect of differing dietary calcium and phosphorus contents on mineral metabolism and bone histomorphometry in young vitamin D-replete baboons. Calcif Tissue Int (1984) 0.85
Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse. Endocrinology (1982) 0.85
Effective doses for strontium ranelate. Osteoporos Int (2008) 0.85
[Cellular aspects of the aging of the articular cartilage. II. Condylar cartilage with fissured surface taken from normal and arthritic knees]. Rev Rhum Mal Osteoartic (1984) 0.85
Effects of transforming growth factor type beta on expression of cytoskeletal proteins in endosteal mouse osteoblastic cells. Bone (1990) 0.85
Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis. Bone (1986) 0.85
Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets. Metab Bone Dis Relat Res (1981) 0.84
Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats. Am J Physiol (1994) 0.84
Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J Bone Miner Res (2001) 0.84
[Derivatives of vitamin D3 in human and cow's milk: sulfate esters of cholecalciferol and 25-hydroxycholecalciferol]. Int J Vitam Nutr Res (1974) 0.84
[Cellular aspects of the aging of articular cartilage. I. Condylar cartilage with a normal surface sampled from normal knees]. Rev Rhum Mal Osteoartic (1984) 0.84
Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis. Metab Bone Dis Relat Res (1981) 0.83
[Vitamin-resistant hypophosphatemic rickets and spinal cord compression. Apropos of 2 cases]. Rev Rhum Ed Fr (1993) 0.83
Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells. J Cell Physiol (1997) 0.83
Osteobiology, strain, and microgravity. Part II: studies at the tissue level. Calcif Tissue Int (2001) 0.83
Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells. Exp Cell Res (2005) 0.83
Histological osteomalacia due to dietary calcium deficiency in children. N Engl J Med (1982) 0.83
Seven-day variable-stress regime alters cortical beta-adrenoceptor binding and immunologic responses: reversal by imipramine. Pharmacol Biochem Behav (1993) 0.82
Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J Bone Miner Res (1993) 0.82
Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol. Kidney Int Suppl (1975) 0.82
Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse. Metabolism (1985) 0.82
1,25-Dihydroxycholecalciferol effect on serum phosphorus homeostasis in rats. Endocrinology (1976) 0.82
Reference intervals for vitamins B1, B2, E, D, retinol, beta-carotene, and folate in blood: usefulness of dietary selection criteria. Clin Chem (1986) 0.82
Distinct effects of calcium- and cyclic AMP-enhancing factors on cytoskeletal synthesis and assembly in mouse osteoblastic cells. Biochim Biophys Acta (1990) 0.82
Skeletal unloading in rat decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am J Physiol (1993) 0.82
Bone changes due to pregnancy and lactation: influence of vitamin D status. Am J Physiol (1986) 0.81